Mirtazapine augmentation in treatment-resistant major depressive disorder: an open-label, six-week trial

Aydemir, OTaskin, EODeveci, A2025-04-102025-04-100924-977Xhttp://hdl.handle.net/20.500.14701/33927EnglishMirtazapine augmentation in treatment-resistant major depressive disorder: an open-label, six-week trialMeeting Abstract